Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
Journal of the American Academy of Dermatology.
Times cited: 45
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease.
Journal of Investigative Dermatology.
Times cited: 14
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
New England Journal of Medicine.
Times cited: 561
Gemcitabine-Related Radiation Recall Preferentially Involves Internal Tissue and Organs.
Times cited: 64